Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323841148> ?p ?o ?g. }
- W4323841148 endingPage "439" @default.
- W4323841148 startingPage "434" @default.
- W4323841148 abstract "SUMMARY OBJECTIVE: The aim of this study was to investigate the predictive importance of the previously validated log(ER)*log(PgR)/Ki-67 predictive model in a larger patient population. METHODS: Patients with hormone receptor positive/HER-2 negative and clinical node positive before chemotherapy were included. Log(ER)*log(PgR)/Ki-67 values of the patients were determined, and the ideal cutoff value was calculated using a receiver operating characteristic curve analysis. It was analyzed with a logistic regression model along with other clinical and pathological characteristics. RESULTS: A total of 181 patients were included in the study. The ideal cutoff value for pathological response was 0.12 (area under the curve=0.585, p=0.032). In the univariate analysis, no statistical correlation was observed between luminal subtype (p=0.294), histological type (p=0.238), clinical t-stage (p=0.927), progesterone receptor level (p=0.261), Ki-67 cutoff value (p=0.425), and pathological complete response. There was a positive relationship between numerical increase in age and residual disease. As the grade of the patients increased, the probability of residual disease decreased. Patients with log(ER)*log(PgR)/Ki-67 above 0.12 had an approximately threefold increased risk of residual disease when compared to patients with 0.12 and below (odds ratio: 3.17, 95% confidence interval: 1.48–6.75, p=0.003). When age, grade, and logarithmic formula were assessed together, the logarithmic formula maintained its statistical significance (odds ratio: 2.47, 95% confidence interval: 1.07–5.69, p=0.034). CONCLUSION: In hormone receptor-positive breast cancer patients receiving neoadjuvant chemotherapy, the logarithmic model has been shown in a larger patient population to be an inexpensive, easy, and rapidly applicable predictive marker that can be used to predict response." @default.
- W4323841148 created "2023-03-11" @default.
- W4323841148 creator A5043498541 @default.
- W4323841148 creator A5053054460 @default.
- W4323841148 creator A5059027606 @default.
- W4323841148 creator A5059478686 @default.
- W4323841148 creator A5060483376 @default.
- W4323841148 creator A5064417858 @default.
- W4323841148 creator A5078547021 @default.
- W4323841148 creator A5080803322 @default.
- W4323841148 date "2023-03-01" @default.
- W4323841148 modified "2023-09-26" @default.
- W4323841148 title "A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy" @default.
- W4323841148 cites W1917103373 @default.
- W4323841148 cites W1967997862 @default.
- W4323841148 cites W2007996727 @default.
- W4323841148 cites W2044702943 @default.
- W4323841148 cites W2063679889 @default.
- W4323841148 cites W2076139950 @default.
- W4323841148 cites W2092624579 @default.
- W4323841148 cites W2105219549 @default.
- W4323841148 cites W2128458647 @default.
- W4323841148 cites W2132893003 @default.
- W4323841148 cites W2165717273 @default.
- W4323841148 cites W2320961624 @default.
- W4323841148 cites W2505493625 @default.
- W4323841148 cites W2573889804 @default.
- W4323841148 cites W2782941313 @default.
- W4323841148 cites W2999400187 @default.
- W4323841148 cites W3113238586 @default.
- W4323841148 cites W3135892092 @default.
- W4323841148 cites W3204278108 @default.
- W4323841148 cites W3211851916 @default.
- W4323841148 cites W4211123279 @default.
- W4323841148 doi "https://doi.org/10.1590/1806-9282.20221255" @default.
- W4323841148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36921198" @default.
- W4323841148 hasPublicationYear "2023" @default.
- W4323841148 type Work @default.
- W4323841148 citedByCount "0" @default.
- W4323841148 crossrefType "journal-article" @default.
- W4323841148 hasAuthorship W4323841148A5043498541 @default.
- W4323841148 hasAuthorship W4323841148A5053054460 @default.
- W4323841148 hasAuthorship W4323841148A5059027606 @default.
- W4323841148 hasAuthorship W4323841148A5059478686 @default.
- W4323841148 hasAuthorship W4323841148A5060483376 @default.
- W4323841148 hasAuthorship W4323841148A5064417858 @default.
- W4323841148 hasAuthorship W4323841148A5078547021 @default.
- W4323841148 hasAuthorship W4323841148A5080803322 @default.
- W4323841148 hasBestOaLocation W43238411481 @default.
- W4323841148 hasConcept C121332964 @default.
- W4323841148 hasConcept C121608353 @default.
- W4323841148 hasConcept C126322002 @default.
- W4323841148 hasConcept C143998085 @default.
- W4323841148 hasConcept C144301174 @default.
- W4323841148 hasConcept C146357865 @default.
- W4323841148 hasConcept C151730666 @default.
- W4323841148 hasConcept C151956035 @default.
- W4323841148 hasConcept C156957248 @default.
- W4323841148 hasConcept C2778217198 @default.
- W4323841148 hasConcept C2908647359 @default.
- W4323841148 hasConcept C38180746 @default.
- W4323841148 hasConcept C44249647 @default.
- W4323841148 hasConcept C530470458 @default.
- W4323841148 hasConcept C58471807 @default.
- W4323841148 hasConcept C62520636 @default.
- W4323841148 hasConcept C65409693 @default.
- W4323841148 hasConcept C71924100 @default.
- W4323841148 hasConcept C84606932 @default.
- W4323841148 hasConcept C86803240 @default.
- W4323841148 hasConcept C90924648 @default.
- W4323841148 hasConcept C98717036 @default.
- W4323841148 hasConcept C99454951 @default.
- W4323841148 hasConceptScore W4323841148C121332964 @default.
- W4323841148 hasConceptScore W4323841148C121608353 @default.
- W4323841148 hasConceptScore W4323841148C126322002 @default.
- W4323841148 hasConceptScore W4323841148C143998085 @default.
- W4323841148 hasConceptScore W4323841148C144301174 @default.
- W4323841148 hasConceptScore W4323841148C146357865 @default.
- W4323841148 hasConceptScore W4323841148C151730666 @default.
- W4323841148 hasConceptScore W4323841148C151956035 @default.
- W4323841148 hasConceptScore W4323841148C156957248 @default.
- W4323841148 hasConceptScore W4323841148C2778217198 @default.
- W4323841148 hasConceptScore W4323841148C2908647359 @default.
- W4323841148 hasConceptScore W4323841148C38180746 @default.
- W4323841148 hasConceptScore W4323841148C44249647 @default.
- W4323841148 hasConceptScore W4323841148C530470458 @default.
- W4323841148 hasConceptScore W4323841148C58471807 @default.
- W4323841148 hasConceptScore W4323841148C62520636 @default.
- W4323841148 hasConceptScore W4323841148C65409693 @default.
- W4323841148 hasConceptScore W4323841148C71924100 @default.
- W4323841148 hasConceptScore W4323841148C84606932 @default.
- W4323841148 hasConceptScore W4323841148C86803240 @default.
- W4323841148 hasConceptScore W4323841148C90924648 @default.
- W4323841148 hasConceptScore W4323841148C98717036 @default.
- W4323841148 hasConceptScore W4323841148C99454951 @default.
- W4323841148 hasIssue "3" @default.
- W4323841148 hasLocation W43238411481 @default.
- W4323841148 hasLocation W43238411482 @default.